Reactive arthritis following COVID-19, its management strategies Ft Dr (Prof) Raju Vaishya - Video

Published On 2023-03-29T10:00:00+05:30 | Updated On 29 March 2023 2:06 PM IST

Overview

We all are aware that immune-mediated conditions associated with COVID-19 have been reported, including vasculitis, antiphospholipid antibody syndrome, myositis, and lupus. Emerging studies have reported the potential occurrence of reactive arthritis in patients previously infected with COVID-19.

A systematic review in Journal of Orthopaedic Surgery and Research summarized the current evidence on the occurrence of reactive arthritis in patients previously infected by COVID-19.

This study was conducted according to the 2020 PRISMA guidelines. The data on COVID-19 severity and management were retrieved such as type of treatment, hospitalization regimes (inpatient or outpatient), admission to the intensive care unit, need of mechanical ventilation, pharmacological management. The following data on reactive arthritis were collected: time elapsed between COVID-19 infection to the onset of reactive arthritis symptoms (days), pharmacological management, type of arthritis (mono- or bilateral, mono- or polyarticular), extra-articular manifestations, presence of tenosynovitis or enthesitis, synovial examination at microscopic polarised light, imaging , clinical examination, laboratory findings.

Data from 54 patients were retrieved out of which 54% were women. The mean time span between COVID-19 infection and the occurrence of reactive arthritis symptoms was around 22 days. Symptoms resolved within few days in all studies considered. At last follow-up, all patients were minimally symptomatic or asymptomatic, and no additional therapy or attentions were required by any patient.

In today’s video, we discuss about this research with Dr. (Prof) Raju Vaishya who is a renowned Orthopedics and joint replacement surgeon with 35 years experience. Dr. Vaishya is currently a Senior consultant at Indraprastha Apollo Hospital, New Delhi.

Reference:

Migliorini, F., Bell, A., Vaishya, R. et al. Reactive arthritis following COVID-19 current evidence, diagnosis, and management strategies. J Orthop Surg Res 18, 205 (2023). https://doi.org/10.1186/s13018-023-03651-6.

Speakers

Dr. Nandita Mohan

BDS, MDS( Pedodontics and Preventive Dentistry)

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Dr Raju Vaishya

Dr. Raju Vaishya is a renowned Orthopedics and joint replacement surgeon having an experience of more than 35 years. He is currently a Senior Consultant at Indraprastha Apollo Hospital, New Delhi. His interest lies in Knee & Hip Surgery (Total Joint Replacement &; Arthroscopic Surgery), Regenerative therapy in orthopedics.

Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751